Top Growth Trends in the Nuclear Medicine Radioisotopes Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNuclear Medicine Radioisotopes Market?
A rise in cardiovascular diseases is expected to boost the nuclear medicine radioisotope market. Contributing factors include inactivity, poor diets, aging, and obesity. Radioisotopes are crucial for diagnosing and managing these conditions. In September 2024, the British Heart Foundation reported 7.6 million UK residents had heart or circulatory diseases, causing 27% of all UK deaths—roughly 170,000 annually. Thus, growing cases promote market expansion.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16132&type=smp
#How Does the ProjectedNuclear Medicine Radioisotopes Market Growth Compare Over the Forecast Period?
The nuclear medicine radioisotopes market expanded from $8.21 billion in 2024 to $8.94 billion in 2025 at a CAGR of 8.9%. Growth stemmed from the discovery of radioactivity, advancements in nuclear medicine, therapeutic applications, clinical research, and patient interest.
The nuclear medicine radioisotopes market is expected to grow strongly, reaching $12.4 billion by 2029 at a CAGR of 8.5%. Growth drivers include increased healthcare spending, healthcare infrastructure expansion, environmental sustainability awareness, education programs, and medical tourism. Trends include new radioisotope development, supply chain innovations, microfluidics and lab-on-a-chip technology, AI in radiopharmaceuticals, and nanotechnology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16132
What Are the Current Market Growth and Trends in theNuclear Medicine Radioisotopes Market That Industry Players Should Watch?
Companies in the nuclear medicine radioisotopes market are introducing innovations like compact low-energy cyclotrons for improved isotope production. In January 2022, IBA, a Belgium-based radiopharmaceutical firm, launched Cyclone Key, a compact, automated accelerator enabling in-house isotope production with multiple output capabilities and simplified installation.
What Are the Major Market Players Making an Impact on theNuclear Medicine Radioisotopes Market Growth?
Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczac?ba??-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Nuclear Medicine Radioisotopes Market Driving Opportunities and Innovations?
The nuclear medicine radioisotopes market covered in this report is segmented –
1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users
Subsegments:
1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging
6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment
7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment
8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo)
9) By Alpharadin (Radium-223 Alpha Emitters): Alpharadin For Bone Metastasis Treatment
10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16132&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNuclear Medicine Radioisotopes Market?# Market Expansion?
North America was the largest region in the nuclear medicine radioisotopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Nuclear Medicine Radioisotopes Market 2025, By The Business Research Company:
Nuclear Fusion Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nuclear-fusion-global-market-report
Nuclear Decommissioning Services Global Market Report 2024
Nuclear Electricity Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nuclear-electricity-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
